Attached files
file | filename |
---|---|
10-K - FORM 10-K - Actavis, Inc. | a55319e10vk.htm |
EX-31.2 - EX-31.2 - Actavis, Inc. | a55319exv31w2.htm |
EX-21.1 - EX-21.1 - Actavis, Inc. | a55319exv21w1.htm |
EX-31.1 - EX-31.1 - Actavis, Inc. | a55319exv31w1.htm |
EX-23.1 - EX-23.1 - Actavis, Inc. | a55319exv23w1.htm |
EX-32.1 - EX-32.1 - Actavis, Inc. | a55319exv32w1.htm |
Exhibit 32.2
Certification
of Chief Financial Officer
Pursuant to 18 U.S.C. of Section 1350, as Created by Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. of Section 1350, as Created by Section 906 of the Sarbanes-Oxley Act of 2002
The undersigned officer of Watson Pharmaceuticals, Inc. (the
Company), hereby certifies, to such officers
knowledge, that:
(i) the Annual Report on
Form 10-K
of the Company for the year ended December 31, 2009 (the
Report) fully complies with the requirements of
Section 13(a) or Section 15(d), as applicable, of the
Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly
presents, in all material respects, the financial condition and
results of operations of the Company.
Date: March 1, 2010
By: |
/s/
R. TODD JOYCE
|
R. Todd Joyce
Senior Vice President Chief Financial Officer
(Principal Financial Officer)
The foregoing certification is being furnished solely to
accompany the Report pursuant to 18 U.S.C.
§ 1350, and is not being filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as
amended, and is not to be incorporated by reference into any
filing of the Company, whether made before or after the date
hereof, regardless of any general incorporation language in such
filing.